5 articles, transcripts, and reports
Financial Performance and Liquidity Altimmune reported a net loss of $27.4 million, or $0.27 per share, for the fourth quarter...
Altimmune, inc (NASDAQ: ALT) Q2 2021 Earnings Conference
Altimmune, inc (NASDAQ: ALT) Q1 2021 Earnings Conference
A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment…
Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year 2019. Revenues totaled $5.8 million compared to $10.3 million last year. The drop in revenues…
